Antidiabetic Potential of Five Flower Remedy: A Thai Traditional Remedy With α‐Amylase and α‐Glucosidase Inhibition, Synergistic Interactions, and Mechanistic Insights

Five Flower Remedy (FFR), a Thai traditional medicine, has a history of use for various ailments. This study investigated its antidiabetic potential by examining its impact on key carbohydrate-metabolizing enzymes, α-amylase, and α-glucosidase. We explored FFR's inhibitory effects, synergistic interactions with the standard antidiabetic drug acarbose, and the underlying mechanisms involved. <i>In vitro</i> analysis revealed that FFRA significantly inhibited both α-amylase and α-glucosidase. Importantly, a synergistic effect was observed when FFRA extract was combined with acarbose, particularly at low concentrations for α-amylase and α-glucosidase inhibition. This suggests a potential benefit in combination therapy. Furthermore, FFRE demonstrated greater inhibitory potency against both enzymes compared to acarbose. Mechanistically, FFRE inhibited α-amylase through competitive inhibition and α-glucosidase through noncompetitive inhibition, indicating distinct modes of action. These findings provide scientific validation for the traditional use of FFR in managing diabetes and offer valuable insights into its pharmacological properties. The observed synergistic effects and distinct inhibition mechanisms highlight FFR's potential as a therapeutic agent. This study serves as a foundation for future research, including identifying the specific bioactive components responsible for FFR's antidiabetic effects, <i>in vivo</i> studies to confirm these findings in living organisms, and ultimately, clinical trials to evaluate its efficacy and safety in human subjects. Further investigation could pave the way for developing FFR as a novel therapeutic approach for diabetes management.

Authors

Institutions

Publication Details

Journal
Scientifica
Published
2025-01-01
DOI
https://doi.org/10.1155/sci5/5516791
Citations
1
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antidiabetic Potential of Five Flower Remedy: A Thai Traditional Remedy With α‐Amylase and α‐Glucosidase Inhibition, Synergistic Interactions, and Mechanistic Insights

Prapaporn Chaniad, Surat Sangkaew, Piriya Chonsut, Ichwan Ridwan Rais et al.
1 citations
Scientifica
Natural Antidiabetic Agents Studies
1.29
article

Antidiabetic Potential of Five Flower Remedy: A Thai Traditional Remedy With α‐Amylase and α‐Glucosidase Inhibition, Synergistic Interactions, and Mechanistic Insights

Prapaporn Chaniad, Surat Sangkaew, Piriya Chonsut, Ichwan Ridwan Rais, Thanchanok Limcharoen
article en
1 citations

Abstract

Five Flower Remedy (FFR), a Thai traditional medicine, has a history of use for various ailments. This study investigated its antidiabetic potential by examining its impact on key carbohydrate-metabolizing enzymes, α-amylase, and α-glucosidase. We explored FFR's inhibitory effects, synergistic interactions with the standard antidiabetic drug acarbose, and the underlying mechanisms involved. <i>In vitro</i> analysis revealed that FFRA significantly inhibited both α-amylase and α-glucosidase. Importantly, a synergistic effect was observed when FFRA extract was combined with acarbose, particularly at low concentrations for α-amylase and α-glucosidase inhibition. This suggests a potential benefit in combination therapy. Furthermore, FFRE demonstrated greater inhibitory potency against both enzymes compared to acarbose. Mechanistically, FFRE inhibited α-amylase through competitive inhibition and α-glucosidase through noncompetitive inhibition, indicating distinct modes of action. These findings provide scientific validation for the traditional use of FFR in managing diabetes and offer valuable insights into its pharmacological properties. The observed synergistic effects and distinct inhibition mechanisms highlight FFR's potential as a therapeutic agent. This study serves as a foundation for future research, including identifying the specific bioactive components responsible for FFR's antidiabetic effects, <i>in vivo</i> studies to confirm these findings in living organisms, and ultimately, clinical trials to evaluate its efficacy and safety in human subjects. Further investigation could pave the way for developing FFR as a novel therapeutic approach for diabetes management.

ScientificaVol. 2025(1)
Chulalongkorn University (TH), Universitas Ahmad Dahlan (ID), Walailak University (TH)
Openalex Percentile: Top 15%
Natural Antidiabetic Agents Studies
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.